Navigation Links
InstaCare Corp. Reviewing M&A Plans
Date:9/26/2007

Board to Consider Proposals and Variations

LOS ANGELES, Sept. 26 /PRNewswire-FirstCall/-- InstaCare Corp. (OTC Bulletin Board: ISCR) a leading e-health Wi-Fi PDA technology provider, the developer of proprietary technologies for medical DME and EMR applications, and the distributor of life saving prescription drugs, medical diagnostics and medical surgical products, announced today that its Board of Directors will begin review of proposals for possible strategic partnerships and/or merger with several companies with interests in strategic areas related to the company's current businesses. The Board of Directors of InstaCare Corp. will meet within the next week to consider these proposals and other opportunities, some previously discussed, with the singular objective to enhance shareholder value. The Board will also discuss the addition of outside director

InstaCare offers a variety of unique products for medical care and management including diabetes monitoring systems, wound care and ostomy products and more. The Company's innovative technology includes a palm-sized computer allowing physicians to have patients' histories, medication and more at hand. ISCR employs a technology push business model, employing its proprietary technologies to add value to the medical products it distributes.

"As a leader in the development of medical IT solutions, we often receive inquiries from other companies who desire to either enter our fast growing market segments, to bolster existing competitive positions without a need to spend on expensive and lengthy product development projects," commented Keith Berman, InstaCare's CFO "We have a responsibility to consider all opportunities and make the decisions which are in the best interest of our shareholders. The latest opportunities we are considering are intriguing, accretive, and potentially highly enriching."

About InstaCare Corp.

InstaCare Corp. is an emerging fulfillment provider
'/>"/>

SOURCE InstaCare Corp.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Oracle Corp. to help build worlds first "Digital Hospital"
2. FDA To Reconsider Standards for Reviewing Low-Dose Oral Contraceptives
3. France plans to protects its citizens from bird flu
4. MSI puts on hold plans for operations in Chennai
5. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
6. Wockhardt Group Plans Hospital In Delhi By End-2007
7. Alberta’s New Reform Plans In Health Care Secto
8. Blue Cross Signs Up 110,000 Minnesotans For Part D Medicare Plans
9. Little Clinic LLC Plans Super Medical Clinics in Publix Super Markets
10. Medicare Drug Plans Are Onerous and Restrictive
11. Rajasthan Plans To Run Christian Institutions
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 2Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 3Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 4Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 5Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 6Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 7Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 8Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 9Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 10Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 11Health News:Pitt study suggests craving hinders comprehension without your realizing it 2Health News:Lilly Announces the First 300-unit Vial of Insulin 2Health News:Lilly Announces the First 300-unit Vial of Insulin 3Health News:Lilly Announces the First 300-unit Vial of Insulin 4Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 2Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 3Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 4Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 5Health News:Pitt study suggests craving hinders comprehension without you realizing it 2
Breaking Medicine Technology:Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 2Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 3Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7EntreMed Reports Second Quarter 2009 Financial Results 53818 1EntreMed Reports Second Quarter 2009 Financial Results 53818 2EntreMed Reports Second Quarter 2009 Financial Results 53818 3EntreMed Reports Second Quarter 2009 Financial Results 53818 4SXC Health solutions announces record second quarter financial results 53815 1SXC Health solutions announces record second quarter financial results 53815 2SXC Health solutions announces record second quarter financial results 53815 3SXC Health solutions announces record second quarter financial results 53815 4SXC Health solutions announces record second quarter financial results 53815 5SXC Health solutions announces record second quarter financial results 53815 6SXC Health solutions announces record second quarter financial results 53815 7SXC Health solutions announces record second quarter financial results 53815 8SXC Health solutions announces record second quarter financial results 53815 9SXC Health solutions announces record second quarter financial results 53815 10SXC Health solutions announces record second quarter financial results 53815 11SXC Health solutions announces record second quarter financial results 53815 12SXC Health solutions announces record second quarter financial results 53815 13SXC Health solutions announces record second quarter financial results 53815 14SXC Health solutions announces record second quarter financial results 53815 15SXC Health solutions announces record second quarter financial results 53815 16SXC Health solutions announces record second quarter financial results 53815 17SXC Health solutions announces record second quarter financial results 53815 18SXC Health solutions announces record second quarter financial results 53815 19Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 1Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 2Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 3Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 4Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 5Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 6Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 7Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 8